1. Home
  2. BBAR vs BEAM Comparison

BBAR vs BEAM Comparison

Compare BBAR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco BBVA Argentina S.A. ADS

BBAR

Banco BBVA Argentina S.A. ADS

N/A

Current Price

$14.55

Market Cap

3.0B

Sector

Finance

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$23.39

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBAR
BEAM
Founded
1886
2017
Country
Argentina
United States
Employees
6493
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
BBAR
BEAM
Price
$14.55
$23.39
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$17.00
$50.75
AVG Volume (30 Days)
832.9K
1.8M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$18.32
N/A
Revenue Next Year
$11.04
$33.77
P/E Ratio
$26.78
N/A
Revenue Growth
N/A
33.33
52 Week Low
$7.76
$20.23
52 Week High
$22.47
$38.26

Technical Indicators

Market Signals
Indicator
BBAR
BEAM
Relative Strength Index (RSI) 38.50 31.80
Support Level $13.43 $21.63
Resistance Level $15.68 $28.96
Average True Range (ATR) 0.71 1.31
MACD 0.12 -0.65
Stochastic Oscillator 26.32 4.41

Price Performance

Historical Comparison
BBAR
BEAM

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: